logo
High Protein In Urine: Is It Time To Screen For Chronic Kidney Disease?

High Protein In Urine: Is It Time To Screen For Chronic Kidney Disease?

News1817-07-2025
Last Updated:
Chronic Kidney Disease can move silently with little to no symptoms until months or even years
One of the most common red flag that doctors look out for is the presence of protein in the urine, as this could significantly deteriorate the kidneys. Chronic Kidney Disease (CKD) is a progressive illness that frequently goes unrecognized until significant kidney damage has already occurred. The Lancet states that CKD is present in approximately 10% of the adult population globally. Moreover, its incidence is on the rise due to the increasing rates of diabetes, hypertension, and unhealthy lifestyle habits. The effective way to manage CKD is through early detection and intervention.
Dr Nitin Shrivastava, Lead Consultant, Urologist, Manipal Hospital, Gurugram shares all you need to know:
What does protein in the urine indicate?
The presence of high levels of protein in the urine indicates the chances are that the kidneys are not functioning as well as they should. This is because protein and other important nutrients are easily able to pass through healthy kidneys and ultimately return to the blood. On the other hand, proteins like albumin leak through the kidney's filters and into the urine in case of dysfunction which is referred to as proteinuria or albuminuria and is among the first and most common signs of Chronic Kidney Disease (CKD). Other symptoms that may imply that the kidneys are not functioning properly include:
● Loss of appetite: Sudden or rapid weight loss without explanation can be attributed to the buildup of toxins in the body that the kidneys can no longer filter.
● Fatigue: Patients may experience a high level of fatigue or weakness and may even have difficulty sleeping. Cramping of muscles is also a common symptom.
● Changes in urination: Frequent urination or a reduced urge to urinate can both be pointing towards damaged kidney function and are often the earliest signs of trouble. It is typically at this stage that individuals decide to go for CKD screening.
● High blood pressure: Chronic conditions like hypertension and diabetes put individuals more at risk of developing kidney disorders. Additionally, impaired kidney function can make it difficult to keep blood pressure under control.
● Swelling in feet and ankles: The inability of kidneys to filter out excess fluid leads to retention, which develops as visible puffiness in the lower limbs.
Why does early screening matter?
Chronic Kidney Disease can move silently with little to no symptoms until months or even years. When individuals finally get tested, the kidneys have already been damaged significantly. In advanced stages, dialysis or a complete kidney transplantation (KTP) are needed to restore function. This involves surgically placing a healthy kidney from a living or deceased donor into the patient's body, offering a more permanent and effective solution in case of kidney failure.
The presence of protein in urine should never be ignored, as it may be the body's earliest warning of silent but progressive kidney damage. However, Regular screening is even more important for individuals with obesity, diabetes, hypertension, or a family history of kidney disease. A simple urine testing can become a life-saving intervention if timely action is taken to prevent further complications.
view comments
First Published:
July 17, 2025, 18:11 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Not just smokers: Doctors flag new risk factors for throat cancer in India
Not just smokers: Doctors flag new risk factors for throat cancer in India

First Post

time17 hours ago

  • First Post

Not just smokers: Doctors flag new risk factors for throat cancer in India

An increasing number of throat cancer cases are being diagnosed among non-smokers in India, particularly men under 60. Experts link this rise to HPV infections, lifestyle changes and environmental exposures. Read here read more Throat cancer, once predominantly associated with tobacco and smoking is increasingly affecting non-smokers in India, particularly men under the age of 60. Medical experts are now sounding the alarm over a dramatic epidemiological shift, citing the human papillomavirus (HPV) as a key driver of this growing trend. 'Traditionally, oropharyngeal cancers in India were largely seen in smokers and tobacco chewers. But now, a growing number of patients, especially men in their 50s—are being diagnosed without any history of smoking,' said Dr Mandeep Singh Malhotra, Director of Surgical Oncology at CK Birla Hospital, Delhi. STORY CONTINUES BELOW THIS AD Dr Malhotra highlighted that areas most commonly affected include the tonsils, base of the tongue, posterior pharyngeal wall and tissues above the voice box. HPV i****nfection the d****riving f****orce The primary factor behind this shift, he said, is the rising incidence of HPV infections which are closely linked to changes in sexual behaviour. 'Increased prevalence of oral sex compared to previous generations has led to higher exposure to HPV, a known carcinogen for the oropharynx,' Dr Malhotra said. A 2023 study published in The Lancet Regional Health – Southeast Asia supports this, reporting that HPV-positive oropharyngeal cancers are on the rise in India, echoing trends observed in Western countries over the past two decades. Other contributing factors include excessive alcohol consumption, poor oral hygiene, a diet low in antioxidants, vegetables and environmental exposure to petrochemicals, wood dust and industrial pollution. Distinct b****iology and b****etter p****rognosis HPV-related throat cancers are biologically different from those caused by tobacco, says Dr. Malhotra. 'They tend to respond much better to chemotherapy and have a higher cure rate, even though they can present at more advanced stages with larger neck nodes. In contrast, cancers linked to smoking and alcohol are often more aggressive and harder to treat.' A 2023 meta-analysis published in JAMA Oncology found that five-year survival rates for HPV-positive oropharyngeal cancer were above 80%, significantly better than the 50-60% rates seen in HPV-negative cases. Breakthroughs in treatment: TORS and bio-Selection Treatment advancements such as Transoral Robotic Surgery (TORS) have revolutionised outcomes, particularly for early-stage patients. 'TORS is minimally invasive, leaves no external scars or bone cuts, and enables faster recovery,' he added. For advanced cases, oncologists are now adopting a 'bio-selection' approach. Patients first receive 2–3 cycles of chemotherapy to assess tumour shrinkage. If the tumour reduces by 50–80%, less invasive options like TORS or radiation can be pursued. If not, a radical surgery followed by radiation becomes necessary. 'This strategy allows us to personalise treatment based on tumour biology rather than a one-size-fits-all approach, ultimately reducing complications and improving survival outcomes,' said Dr Malhotra. According to the Indian Council of Medical Research (ICMR), India sees over 1.3 lakh new cases of head and neck cancers annually, with oropharyngeal cancer forming a significant portion. Globally, WHO estimates that HPV is responsible for up to 70% of oropharyngeal cancers in developed countries, a number now reflecting similar patterns in India. STORY CONTINUES BELOW THIS AD As the medical community adapts to these evolving patterns, awareness and early detection remain key. 'Vaccination against HPV, improved oral hygiene and safe sexual practices are preventive strategies that must be prioritised,' Dr Malhotra said.

Liver Cancer May Kill 1.3 Million By 2050. Here's How to Stop It
Liver Cancer May Kill 1.3 Million By 2050. Here's How to Stop It

NDTV

time2 days ago

  • NDTV

Liver Cancer May Kill 1.3 Million By 2050. Here's How to Stop It

A recent study published in The Lancet warns that liver cancer cases worldwide could nearly double by 2050 if current trends continue. New cases may rise from 870,000 to 1.52 million annually, with projected deaths reaching 1.37 million. Liver cancer is now the third deadliest cancer globally. The study highlights preventable causes such as alcohol use, viral hepatitis (B & C), and MASLD, a liver condition linked to obesity. Experts say that 60% of liver cancer cases could be avoided through early prevention and better public health strategies. The report was released on World Hepatitis Day and urges global action to reduce risk factors and improve awareness. Vaccination at birth is the best way to prevent hepatitis B, but vaccine coverage remains low in poorer countries including in sub-Saharan Africa, the study said. Unless vaccination rates are increased, hepatitis B is expected to kill 17 million people between 2015 and 2030, it added. Alcohol consumption is estimated to cause more than 21 percent of all cases of liver cancer by 2050, up more than two percentage points from 2022. Cancer due to obesity-linked fat in livers will rise to 11 percent, also up more than two percentage points, the researchers calculated. The large-scale study, which reviewed the available evidence on the subject, underscored "the urgent need for global action" on liver cancer, the authors said. The experts called for more public awareness about the preventable danger of liver cancer, particularly by warning people with obesity or diabetes about fatty-liver disease in the United States, Europe and Asia.

3 in 5 liver cancer cases are preventable, experts reveal
3 in 5 liver cancer cases are preventable, experts reveal

Time of India

time2 days ago

  • Time of India

3 in 5 liver cancer cases are preventable, experts reveal

A recent study in The Lancet reveals that 60% of liver cancer cases are preventable by addressing risk factors like viral hepatitis, alcohol consumption, and metabolic dysfunction-associated steatotic liver disease (MASLD). Experts predict a significant rise in MASLD-related liver cancer by 2050, particularly among those with diabetes and obesity. In 2020, about 905,700 people were diagnosed with liver cancer, and 830,200 people died from it. It remains the top three causes of death in many countries. With the incidence of liver diseases on the rise, the numbers could further surge. However, a new study has found that most of the liver cancer cases are preventable. According to a new analysis published in The Lancet , 3 in 5 liver cancer cases are preventable. This is more than 60% of liver cancer cases worldwide. 60% of the liver cancer cases are preventable (Pic courtesy: iStock) The new study found that three in five liver cancer cases are preventable through the reduction of risk factors, including viral hepatitis, alcohol, and metabolic dysfunction-associated steatotic liver disease (MASLD), a long-term liver condition caused by excess fat in the liver. The study on liver cancer predicts that by 2050, liver cancer cases caused by a severe form of MASLD, known as MASH, will rise by 35%, from 8% to 11%. The authors have emphasized the importance of creating public, medical, and political awareness of the rising risk of MASLD, especially in the USA, Europe, and Asia. People with diabetes and obesity are especially at risk. According to the study, new liver cancer cases are predicted to double in the next 25 years if the cause is not addressed. The Commission also suggested that the risk factors can be reduced in several ways, such as increasing the coverage of the hepatitis B vaccine and public health policies that target obesity and alcohol consumption. Previous analyses have predicted that new liver cancer cases will almost double, from 870,000 in 2022 to 1.52 million by 2050, mainly due to population growth and ageing. The biggest rise is expected in Africa. Deaths from liver cancer are projected to increase from 760,000 in 2022 to 1.37 million by 2050. As liver cancer remains a major cause of death and disability, looking at the risk factors is crucial. It is the sixth most common cancer and the third leading cause of death globally. More than 40% of the global liver cancer cases occur in China, mostly due to relatively high rates of hepatitis B infections in the country. 'Liver cancer is a growing health issue around the world. It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%. We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend,' Chair of the Commission, Prof Jian Zhou, Fudan University (China) said in a statement. 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives,' first author, Prof Stephen Chan, Chinese University of Hong Kong (Hong Kong, China) added. Shift in the cause of liver cancer The study stressed that at least 60% of liver cancers are preventable by controlling modifiable risk factors, including hepatitis B virus (HBV), hepatitis C virus HCV, MASLD, and alcohol. The researchers noted that MASLD is a rising risk. Approximately a third of the global population are estimated to have MASLD. However, only 20 to 30% of patients with MASLD develop the more severe form of the condition, with liver inflammation and damage, called metabolic dysfunction-associated steatohepatitis (MASH). The incidence of MASLD-linked liver cancer is expected to go up in the next 10 years, with obesity being the key driver. 'Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease. However, today rising rates of obesity are an increasing risk factor for liver cancer, primarily due to the increase in cases of excess fat around the liver. One approach to identify patients at high risk of liver cancer would be to introduce screening for liver damage into routine healthcare practice for patients at high risk of MASLD, such as individuals living with obesity, diabetes, and cardiovascular disease. Healthcare professionals should also integrate lifestyle counselling into routine care to support patients to transition to a healthy diet and regular physical activity. Furthermore, policy makers must promote healthy food environments via policies such as sugar taxes and clear labelling on products with high fat, salt, and/or sugar,' commission author, Prof Hashem B El-Serag, Baylor College of Medicine (USA) said. What can be done According to the commission, if the incidence of liver cancer cases can be reduced by 2 to 5% each year by 2050, it could prevent nine to 17 million cases of liver cancer and save eight to 15 million lives. As more patients live with liver cancer than ever before, in addition to prevention efforts, there is an urgent need for increased research and attention for these patients to improve their quality of life. Supreme Court Pushes Central Govt to Finalise FOPL: What It Means & Why It Matters? | Explained 'There is an urgent need to raise awareness within society about the severity of the growing health issue of rising liver cancer cases. Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies. With joint and continuous efforts, we believe many liver cancer cases can be prevented and both the survival and quality of patients with liver cancer will be considerably improved,' Commission author, Prof Valérie Paradis, Beaujon Hospital (France) said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store